Eur Rev Med Pharmacol Sci 2020; 24 (15): 7925-7926
DOI: 10.26355/eurrev_202008_22474

Speculative clues on Myasthenia gravis and COVID-19

C. Scoppetta, S. Casciato, G. Di Gennaro

Department of Human Physiology and Pharmacology, La Sapienza University of Rome, Rome, Italy. cscoppetta@tin.it

Free PDF Download

To cite this article

C. Scoppetta, S. Casciato, G. Di Gennaro
Speculative clues on Myasthenia gravis and COVID-19

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 15
Pages: 7925-7926
DOI: 10.26355/eurrev_202008_22474

Keywords Related articles:

  1. Common sense in treating persons suffering from Myasthenia Gravis
  2. Role of ubiquitin ligase Cbl-b in B-cell activation of dendritic cells loaded with Tα146-162 in the treatment of experimental autoimmune myasthenia gravis in mice
  3. Effect of glucocorticoid combined with gamma globulin in treatment of children with myasthenia gravis and its effects on immune globulin and complement of children
  4. Impact of COVID-19 on otolaryngology in Italy: a commentary from the COVID-19 task force of the Young Otolaryngologists of the Italian Society of Otolaryngology
  5. Herd immunity and COVID-19